US Heart & Vascular and health technology company Iterative Health have formed a strategic partnership to expand USHV’s cardiovascular clinical trial capabilities.
The agreement brings USHV’s research sites into Iterative Health’s global site network, which now spans more than 100 locations across three continents. The partnership marks Iterative Health’s expansion beyond its core specialties of GI, hepatology and obesity into cardiology, according to an April 2 news release.
USHV research sites will receive end-to-end operational support through Iterative’s infrastructure, including business development, research operations and technology services. The collaboration aims to scale innovative cardiovascular therapies in community-based settings, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
